Chulalongkorn University, Thailand, and Nagoya University, Japan, in their collaboration to develop an immunotherapy method for curing cancer, reported on the progress of CAR T-cell immunotherapy innovation for treating cancer in leukemia and B-cell lymphoma patients, which can increase survival rates and reduce cancer recurrence. BANGKOK, April 6, 2023 /PRNewswire/ Chulalongkorn University and the Faculty of Medicine, Chulalongkorn University, organized the17thChula the Impact on "CAR T-Cell Cancer Therapy Innovation: New Hope for Thai Cancer Patients"on Tuesday, March 28, 2023, at Saranitet Conference Room, Chulalongkorn Auditorium. The talk presented the progress of CAR T-cell immunotherapy innovation for treating cancer in leukemia and B-cell lymphoma patients. This research project is a collaboration between the Cancer Immunotherapy Excellence Center, Faculty of Medicine, Chulalongkorn University, and King Chulalongkorn Memorial Hospital, Thailand, and Tokai National Hi
Kyoto
Japan
Nagoya
Aichi
United-states
Bangkok
Krung-thep-mahanakhon
Thailand
Thai
Supannikar-tawinwung
Hiroshi-kimura
Thanita-wangvanichapan